Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725263) titled 'Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children' on July 21.
Study Type: Observational [Patient Registry]
Primary Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
Condition:
Thalassemia
Hematopoietic Stem Cell Transplantation
Neutropenia
Invasive Fungal Infections
Graft vs Host Disease
Intervention:
Drug: Liposomal Amphotericin B (LAmB)
Recruitment Status: Recruiting
Date of First Enrollment: February 1, 2026
Target Sample Size: 30
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/stud...